Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11051
CALL
Viking Holdings
VIK
$47.3B
| $84.8K | ﹤0.01% |
+2,500
| New | +$75.4K |
|
11052
CALL
Hycroft Mining Holding Corp
HYMC
$2.48B
| $84.8K | ﹤0.01% |
35,330
+16,290
| +86% | +$53.2K |
|
11053
CALL
YieldMax AI Option Income Strategy ETF
AIYY
$26.8M
| $84.7K | ﹤0.01% |
+720
| New | +$89.3K |
|
11054
Vor Biopharma
VOR
$1.32B
| $84.6K | ﹤0.01% |
4,232
+1,978
| +88% | +$64K |
|
|
ORKA
11055
CALL
Oruka Therapeutics
ORKA
$7.16B
| $84.6K | ﹤0.01% |
1,842
-2,716
| -60% | -$108K |
|
11056
PUT
Relmada Therapeutics
RLMD
$507M
| $84.6K | ﹤0.01% |
28,200
-31,100
| -52% | -$113K |
|
11057
CALL
New Mountain Finance
NMFC
$728M
| $84.5K | ﹤0.01% |
6,900
-5,400
| -44% | -$67.7K |
|
|
MSB
11058
PUT
Mesabi Trust
MSB
$306M
| $84.4K | ﹤0.01% |
4,900
+600
| +14% | +$10.4K |
|
11059
PUT
UL Solutions
ULS
$15.5B
| $84.4K | ﹤0.01% |
+2,000
| New | +$75.7K |
|
11060
PUT
Northwest Bancshares
NWBI
$2.31B
| $84.3K | ﹤0.01% |
7,300
+4,000
| +121% | +$44K |
|
11061
Nutriband Inc Warrant
NTRBW
$263K
| $84.3K | ﹤0.01% |
117,052
+3,863
| +3% | +$3.38K |
|
11062
PUT
Lands' End
LE
$391M
| $84.3K | ﹤0.01% |
6,200
-3,200
| -34% | -$43K |
|
11063
PUT
Inter&Co
INTR
$2.3B
| $84.3K | ﹤0.01% |
13,700
+3,300
| +32% | +$19K |
|
11064
PUT
BioXcel Therapeutics
BTAI
$34.9M
| $84.2K | ﹤0.01% |
4,113
-743
| -15% | -$24.9K |
|
11065
PUT
Cardiff Oncology
CRDF
$77.1M
| $84.1K | ﹤0.01% |
37,900
+18,200
| +92% | +$68.6K |
|
11066
CALL
Enliven Therapeutics
ELVN
$4.25B
| $84.1K | ﹤0.01% |
+3,600
| New | +$75.8K |
|
|
CXH
11067
DELISTED
MFS Investment Grade Municipal Trust
CXH
| $84.1K | ﹤0.01% |
+10,641
| New | +$80.3K |
|
11068
PUT
iShares MSCI USA Min Vol Factor ETF
USMV
$24.6B
| $84K | ﹤0.01% |
1,000
+900
| +900% | +$74.2K |
|
|
LGF.A
11069
PUT
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $83.8K | ﹤0.01% |
8,900
-11,600
| -57% | -$112K |
|
|
API
11070
Agora
API
$408M
| $83.7K | ﹤0.01% |
39,462
-1,462
| -4% | -$3.69K |
|
11071
PUT
Rayonier Advanced Materials
RYAM
$561M
| $83.2K | ﹤0.01% |
15,300
-85,500
| -85% | -$416K |
|
11072
PUT
ProShares UltraShort Dow 30
DXD
$42.6M
| $83.2K | ﹤0.01% |
2,600
-5,800
| -69% | -$189K |
|
11073
CALL
ICU Medical
ICUI
$4.58B
| $83.1K | ﹤0.01% |
700
-100
| -13% | -$10.5K |
|
11074
DNP Select Income Fund
DNP
$4.12B
| $83.1K | ﹤0.01% |
10,109
-20,373
| -67% | -$177K |
|
11075
Cadre Holdings
CDRE
$1.44B
| $83.1K | ﹤0.01% |
2,476
-800,924
| -100% | -$26.4M |
|
Similar funds
Citadel Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Citadel Advisors held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citadel Advisors withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Carrier Global worth $140M.
- Citadel Advisors's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Citadel Advisors added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Citadel Advisors's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Citadel Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Citadel Advisors's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Citadel Advisors opened 1,435 new positions and closed 1,760 in Q2 2024.
- Citadel Advisors's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.